A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
NCT00002187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
Conditions
- Cytomegalovirus Retinitis
- HIV Infections
Interventions
- DRUG
-
Fomivirsen sodium
Sponsors & Collaborators
-
Ionis Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy
NCT00002247 ·Status: COMPLETED ·Phase: NA
-
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS
NCT00002222 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002377 ·Status: COMPLETED ·Phase: PHASE3
-
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
NCT00000726 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002432 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
NCT00001061 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
NCT00000691 ·Status: COMPLETED ·Phase: PHASE2
-
Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
NCT00000665 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002437 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir
NCT00002301 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002257 ·Status: COMPLETED ·Phase: NA
-
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
NCT00000697 ·Status: WITHDRAWN ·Phase: PHASE2
-
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
NCT00017784 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002330 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV
NCT00001034 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)
NCT00002125 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
NCT00002039 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS
NCT00002034 ·Status: COMPLETED ·Phase: NA
-
A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
NCT00000673 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
NCT00001999 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS
NCT00002142 ·Status: COMPLETED ·Phase: NA
-
Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
NCT00000134 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Activity Against CVM Retinitis
NCT00001611 ·Status: COMPLETED